Caturday quickie, part the second: Pupdate


The last time I offered a pupdate, Nuala had been diagnosed with diabetes, we had a VetPen, but were having difficulty regulating her blood sugar. We’d also stopped the prednisone and started an alternate treatment, cyclosporin.

Well, after three glucose curves, her blood sugar is still not regulated, but the vet feels that clinically, she’s doing fine. The stress of a day-long stay at the vet’s may have an impact on her glucose readings, however. So we’re continuing her treatment of 16 units of insulin twice a day.

We ended up returning the VetPen as the maximum dose on it is 16 units and we may have to increase her dosage again, depending on how her symptoms are managed. Phil and I are much more comfortable with syringes anyway, having had previous experience with our cat, Thufir (the caturday quickie mascot).

The cyclosporin was not working and her ears (which the pred and the cyclosporin were prescribed to treat) were once again full of cysts. She had an abscess in one ear, as evidenced by the amount of pus that came out of it, and so the vet has recommended a return to the pred. We have to monitor her water intake and urination and may have to adjust her insulin accordingly . . . because . . .

Nu is once more a piddle pup, incontinence being one of several side effects of the pred. We now have washable incontinence pads made for humans on the bed and the couch, and are otherwise tolerating the occasional dribble. She can’t help it, poor dear.

Other than that, she’s on Fortekor for her proteinurea.

That’s our complex pup in a nutshell.

After only a few days on the pred, her ear cysts are shrinking again, and she seems quite happy.

Nuala December 2014

This is seriously the best picture I could get of her. She’s absurdly camera shy (!)

Our aim is quality of life. She’s nine and a half, even though we still refer to her as the pup.

I hope this will be the last pupdate for a while.

Caturday Quickies

2 thoughts on “Caturday quickie, part the second: Pupdate

Comments are closed.